home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Overview of Drug Development

 
  May 09, 2008  
     
 
Drug Information Association, Renaissance Philadelphia Hotel Airport, Philadelphia, PA, USA
Aug 18 2008


This course provides an overview of how new pharmaceutical products are identified and developed. The roles and interactions among marketing, clinical R&D, regulatory affairs, and manufacturing will be reviewed. A basic description of the Investigational New Drug Application (IND) will lead to a review of how clinical trials are started, completed, and reported; ethical considerations in conducting clinical research; filing a New Drug Application (NDA) and interactions with the FDA. The course material focuses on developing drugs and biologics under FDA regulations and ICH guidelines.
 
 
Organized by: Drug Information Association
Invited Speakers: Bernie Ott Consultant United States. John C. Schneider Senior PartnerJ DS Consulting United States.
 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=15368&eventType=Training%20Course
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.